TY  - ADVS
AU  - HARISH K
TI  - Formulation and Evaluation of Transdermal patches of Losartan
U1  - 338.476 151 
PY  - 2010///
KW  - Industrial Pharmacy(338.476 151)
N1  - Evaluation ; Formulation ; Losartan ; patches ; Transdermal
ER  -